Myasthenia Gravis Introduction Myasthenia gravis is a disease that affects the muscles, causing them to become weak. Medication is available to treat myasthenia gravis. However, medical emergencies can arise if the dise

First Page		Document Content
Date: 2014-04-30 11:19:08 Neurological disorders Autoimmune diseases Quaternary ammonium compounds Myasthenia gravis Acetylcholinesterase inhibitors Acetylcholine Thymus Weakness Edrophonium Health Medicine Biology		Myasthenia Gravis Introduction Myasthenia gravis is a disease that affects the muscles, causing them to become weak. Medication is available to treat myasthenia gravis. However, medical emergencies can arise if the dise Add to Reading List Source URL: www.nlm.nih.gov Download Document from Source Website File Size: 160,53 KB Share Document on Facebook

	Utox.qxd, page 1-4 @ NormalizeUtox.qxd ) DocID: 1qGCx - View Document
	Volume II, Chapter 2: Appendix 2.A Appendix 2.A Tables for Section 2.4, Characterization of Well Stimulation Fluids DocID: 1qhiJ - View Document
	Microsoft Word - Ethidium Bromide Treatment and Disposal v2.1.doc DocID: 1qh7N - View Document
	There is a lot of research information available now on carnitine, that wasn’t around when we first started looking at carnitine supplementation for polios in 1994 and recording carnitine blood levels via PMH. Answers DocID: 1pSCZ - View Document
	Trimethylamine-N-oxide (TMAO) and cardiovascular outcome Manuel Ottiger, MD, Department of Internal Medicine Swiss MedLab Bern, Dietary-associated and intestinal microbiota-dependent DocID: 1pScc - View Document